Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction

Journal of Vascular Surgery

Volumn 31, Issue 2, 2000, Pages 375-381

  Mawatari, Kyotaro ^a   Liu, Bo ^a   Kent, K Craig ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GROWTH FACTOR; INTEGRIN; INTEGRIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0033981817     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(00)90167-8     Document Type: Article

References (41)

1. Donaldson MC, Mannick JA, Whittemore AD. Causes of primary graft failure after in situ saphenous vein bypass grafting. J Vasc Surg 1992;15:113-20.
2. Chervu A, Moore WS. An overview of intimai hyperplasia. Surg Gynecol Obstet 1990;171:433-40.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
4. Hynes RO. Integrin: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
5. Smyth SS, Joneckis CC, Parise LV. Reguration of vascular integrins. Blood 1993;81:2827-43.
6. Juriano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577-85.
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76: 301-14.
8. Skinner MP, Raines EW, Ross R. Dynamic expression of α1β1 and α2β1 integrin receptors by human vascular smooth muscle cells. α2β1 integrin is required for chemotaxis across type I collagen-coated membranes. Am J Pathol 1994;145:1070-81.
9. Seki J, Koyama N, Kovach NL, Yednock T, Clowes AW, Harlan JM. Regulation of β1-integrin function in cultured human vascular smooth muscle cells. Circ Res 1996;78:596-605.
10. Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA *. J Vasc Surg 1994;19:125-34.
11. Itoh H, Nelson PR, Mureebe L, Horowitz A, Kent KC. The role of integrins in saphenous vein vascular smooth muscle cell migration. J Vasc Surg 1997;25:1061-9.
12. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, et al. Potential roles of osteopontin and αvβ3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci U S A 1997; 94:9308-13.
13. Srivatsa SS, Fitzpatrick LA, Tsao PW, Reilly TM, Holmes DR Jr, Schwartz RS. Selective αvβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury; evidence for the functional importance of integrin avb3 and osteopontin expression during neointima formation. Cardiovasc Res 1997;36:408-28.
14. Hoshiga M, Alpers CE, Smith LL, Giachelli CM, Schwarz SM. αvβ3 Integrin expression in normal and atherosclerotic artery. Circ Res 1995;77:1129-35.
15. Pickering JG, Uniyal S, Ford CM, Chau T, Laurin MA, Chow LH, et al. Fibroblast growth factor-2 potentiates vascular smooth muscle cell migration to platelet-derived growth factor: upregulation of α2β1 integrin and disassembly of actin filaments. Circ Res 1997;80:627-37.
16. Wang XQ, Frazier WA. The thrombospondin receptor CD47 (IAP) modulates and associates with α2β1 integrin in vascular smooth muscle cells. Mol Biol Cell 1998;9:865-74.
17. Itoh H, Mureebe L, Kubaska S, Kent KC. Type I collagen enhances phosphorylation of the PDGF-induced vascular smooth muscle cell proliferation. Surg Forum XLVIII 1997;406-8.
18. Koyama N, Seki J, Vergal S, Mattasson EJ, Yednock T, Kovach NL, et al. Regulation and function of an activation dependent epitope of the β1 integrins in vascular cells after balloon injury in baboon arteries and in vitro. Am J Pathol 1996;148:749-60.
19. Stouffer GA, Hu Z, Sajid M, Li H, Jin G, Nakada MT, et al. β3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 1998;97:907-15.
20. Hedin U, Daum G, Clowes AW. Disruption of integrin α5β1 signaling does not impair PDGF-BB-mediated stimulation of the extracellar signal regulated kinase pathway in smooth muscle cells. J Cell Physiol 1997;172:109-16.
21. Miyamoto S, Akiyama SK, Yamada KM. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 1995;267:883-5.
22. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. Integrins can collaborate with growth factors phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 1996;135:1633-42.
23. Kaiura TL, Itoh H, Kubaska SM, McCaffrey TA, Bo Liu, Kent KC. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg. In press 1999.
24. Wayner EA, Carter WG. Identification of multiple cell adhesion receptor for collagen and fibronectin in human fibrosarcoma cells possessing unique a and b subunits. J Cell Biol 1987;105:1873-84.
25. Carter WG, Wayner EA, Bouchard TS, Kaur P. The role of α2β1 and α3β1 in cell-cell and cell substrate adhesion of human epidermal cells. J Cell Biol 1990;110:1387-404.
26. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J Clin Invest 1999;103:47-54.
27. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994;264(22): 569-71.
28. Mii S, Ware JA, Kent KC. Transforming growth factor-β inhibits human vascular smooth muscle cell growth and migration. Surgery 1993;114:262-70.
29. Mii S, Khalil RA, Morgan KG, Ware JA, Kent KC. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol 1996;270:H142-H150 (Heart Circ Physiol 39).
30. Jones JI, Prevette T, Gockerman A, Clemmons DR. Ligand occupancy of the αvβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Nathl Acad Sci USA 1996;93:2482-7.
31. Basson CT, Kocher O, Basson MD, Asis A, Madri JA. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-β1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992; 153:118-28.
32. Janat MF, Argraves WS, Liau G. Regulation of vascular smooth muscle cell integrin expression by transforming growth factor betal and by platelet-derived growth factor-BB. J Cell Physiol 1992;151:588-95.
33. Jones PL, Crack J, Rabinovitch M. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the αvβ3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 1997; 139:279-93.
34. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A 1992; 89:8487-91.
35. Kornberg LJ, Earp HS, Turner CE, Prockop C, Juliano RL. Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc Natl Acad Sci U S A 1991;88:8392-6.
36. McNamee HP, Ingber DE, Schwartz MA. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Cell Biol 1993;121:73-8.
37. Rankin S, Rozengurt E. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J Biol Chem 1994;269:704-10.
38. Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL. Integrin-mediated cell adhesion activates mitogen-activated proteins kinases. J Biol Chem 1994;269:26602-5.
39. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 1994;91:10148-52.
40. Chen HC, Guan JL. Stimulation of phosphatidylinositol 3-kinase association with focal adhesion kinase by platelet-derived growth factor. J Biol Chem 1994;269:31229-33.
41. Rankin S, Hooshmand-Rad R, Claesson-Welsh L, Rozengurt E. Requirement for phosphatidylinositol 3-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J Biol Chem 1996;271:7829-34.